Understanding Parkinson's Disease in Black and African American Communities
Official title: Black and African Americans Connections to Parkinson's Disease (BLAAC PD) A Project of the Global Parkinson's Genetics Program (GP2)
Run by Michael J. Fox Foundation for Parkinson's Research · NCT06719583 · Data updated 2026-11-12
This study is trying to learn more about the genetic factors of Parkinson's disease in Black and African American communities to help improve diagnosis and treatment for those affected.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Michael J. Fox Foundation for Parkinson's Research Academic / other |
| Locations | 12 sites (Birmingham, Alabama and 11 other locations) |
| Status | Recruiting |
| Started | November 16, 2020 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | February 27, 2026 |
| Trial ID | NCT06719583 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Black or African American individuals aged 18 years or older, either diagnosed with Parkinson's disease or without any neurological conditions.
✕Probably not a fit
Patients who do not identify as Black or African American or those with a diagnosis of Parkinson's disease or other neurological conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
BLAAC PD is an observational study aimed at exploring the genetic factors associated with Parkinson's disease specifically in Black and African American populations. Participants will provide blood or saliva samples, undergo a smell test, and may participate in a physical exam during a single visit at various research centers across the United States. This initiative is part of the Global Parkinson's Genetics Program, which seeks to enhance the understanding of Parkinson's disease genetics and its implications for diverse communities. The findings could lead to improved diagnostic tools and treatments tailored for Black and African American individuals affected by Parkinson's disease.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and treatment options for Parkinson's disease in Black and African American patients.
How similar studies have gone: While studies have explored genetic factors in Parkinson's disease, this specific focus on Black and African American populations is novel and addresses a significant gap in existing research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Control Participants: * Ability to provide informed consent * Age 50 years or older * Self-identify as Black or African American Exclusion Criteria for Control Participants: * Diagnosis of Parkinson's Disease and/or neurological condition * Familial history of PD and/or neurodegenerative or psychiatric conditions * Unknown family history of PD and/or neurodegenerative or psychiatric conditions * Any conditions that, in the investigator's opinion, preclude the individual's ability to carry out study activities * If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection Inclusion Criteria for Participants with a Diagnosis of PD: * Ability to provide informed consent * Age 18 years or older * Self-identify as Black or African American * Meet the Movement Disorder Society's clinical diagnostic criteria for Parkinson's disease Exclusion Criteria for Participants with a Diagnosis of PD: \- If submitting a saliva sample, nothing by mouth (food, drink, gum, tobacco, or smoking) for 30 minutes prior to sample collection
Where it's running
-
University of Alabama at Birmingham
Birmingham, Alabama, United States Recruiting -
University of Florida
Gainesville, Florida, United States Recruiting -
Rush University
Chicago, Illinois, United States Recruiting -
University of Chicago
Chicago, Illinois, United States Recruiting -
Ochsner Clinic Foundation
New Orleans, Louisiana, United States Recruiting -
Louisiana State University Health Sciences Center Shreveport
Shreveport, Louisiana, United States Recruiting
Show 6 more locations
-
University of Maryland
Baltimore, Maryland, United States Recruiting -
Washington University in St. Louis
St Louis, Missouri, United States Recruiting -
University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
University of Texas Health Science Center, Houston
Houston, Texas, United States Recruiting -
Kaiser Permanente Midatlantic States
Rockville, Maryland, United States Active not recruiting
Study contacts
- Principal investigator: Lana Chahine, MD, PhD — University of Pittsburgh
- Study coordinator: Naomi Louie, MPH RDN
- Email: nlouie@michaeljfox.org
- Phone: 212-509-0995
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.